COLONY GROUP LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 259 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.43 and the average weighting 0.4%.

Quarter-by-quarter ownership
COLONY GROUP LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,209,000
-7.6%
11,590
-11.9%
0.03%
-26.2%
Q3 2019$1,309,000
-20.6%
13,154
-8.9%
0.04%
-19.2%
Q2 2019$1,649,000
-9.1%
14,446
+0.1%
0.05%
-31.6%
Q1 2019$1,814,000
-0.3%
14,433
+7.6%
0.08%
-13.6%
Q4 2018$1,820,000
-46.0%
13,410
+9.1%
0.09%
-47.6%
Q3 2018$3,372,000
+29.7%
12,286
-2.1%
0.17%
+23.5%
Q2 2018$2,600,000
-15.5%
12,550
-32.6%
0.14%
-18.6%
Q1 2018$3,076,000
+18.7%
18,622
-1.6%
0.17%
+3.1%
Q4 2017$2,591,000
-7.9%
18,920
-8.4%
0.16%
-15.6%
Q3 2017$2,813,000
+5.8%
20,660
-5.7%
0.19%
+1.6%
Q2 2017$2,659,000
+13.4%
21,899
-1.2%
0.19%
-14.5%
Q1 2017$2,345,000
+2.2%
22,154
-1.9%
0.22%
-10.2%
Q4 2016$2,295,000
-0.0%
22,589
+0.4%
0.25%
-3.5%
Q3 2016$2,296,000
-16.9%
22,498
-2.9%
0.26%
-16.1%
Q2 2016$2,764,000
+8.6%
23,178
-2.4%
0.30%
+3.4%
Q1 2016$2,544,000
-1.5%
23,760
-0.3%
0.29%
+24.6%
Q4 2015$2,583,000
+27.9%
23,820
+1.0%
0.24%
+0.4%
Q3 2015$2,020,00023,5900.24%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
VILLERE ST DENIS J & CO LLC 518,988$80,162,0004.60%
Knott David M Jr 75,000$11,585,0003.93%
Orchard Capital Management, LLC 68,596$10,595,0003.11%
Chicago Capital, LLC 436,456$67,415,0002.51%
RICE HALL JAMES & ASSOCIATES, LLC 347,699$53,706,0001.91%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 85,990$13,282,0001.46%
Smith, Graham & Co., Investment Advisors, LP 87,392$13,499,0001.34%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 44,754$6,913,0001.12%
WOODSTOCK CORP 68,666$10,606,0001.11%
Stephens Investment Management Group LLC 411,359$63,539,0000.82%
View complete list of LIGAND PHARMACEUTICALS INC shareholders